Qurient Co., Ltd. (KOSDAQ:115180)
45,050
-1,550 (-3.33%)
At close: Mar 19, 2026
Qurient Market Cap
Qurient has a market cap or net worth of 1.82 trillion as of March 20, 2026. Its market cap has increased by 760.71% in one year.
Market Cap
1.82T
Enterprise Value
1.78T
Revenue
8.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
45,050.00
Market Cap Chart
Since February 29, 2016, Qurient's market cap has increased from 281.86B to 1.82T, an increase of 544.43%. That is a compound annual growth rate of 20.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.82T | 53.24% |
| Dec 30, 2025 | 1.19T | 674.51% |
| Dec 30, 2024 | 153.05B | 69.38% |
| Dec 28, 2023 | 90.36B | -24.77% |
| Dec 29, 2022 | 120.11B | -63.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 3.64T |
| Rznomics | 2.99T |
| ROKIT Healthcare | 2.04T |
| AprilBio | 1.46T |
| JS Link | 1.37T |
| Inventage Lab | 1.06T |
| HansBiomed | 755.85B |
| IntoCell | 711.57B |